<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND/AIMS: <z:hpo ids='HP_0002020'>Gastroesophageal reflux disease</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e>) is a common <z:e sem="disease" ids="C0017178" disease_type="Disease or Syndrome" abbrv="">gastrointestinal disease</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>This study was designed to examine current epidemiology, diagnosis, management, and treatment of patients diagnosed with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> by surveying physicians in several East Asian countries </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: A questionnaire-based survey was completed in six countries including China, Indonesia, Japan, Korea, the Philippines, and Thailand between July 2008 and December 2008 </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: In total, 876 physicians participated in the study </plain></SENT>
<SENT sid="4" pm="."><plain>Most physicians in <z:hpo ids='HP_0000001'>all</z:hpo> countries, except Japan, frequently used international guidelines for the care of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> patients, whereas approximately half of Japanese physicians did not use such guidelines </plain></SENT>
<SENT sid="5" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> was common among many patients, but <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, particularly the long-segmental type, was rare </plain></SENT>
<SENT sid="6" pm="."><plain>The incidence of <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancer</z:e>, particularly <z:mp ids='MP_0009308'>adenocarcinoma</z:mp>, was high in China, but low in other countries </plain></SENT>
<SENT sid="7" pm="."><plain>Most physicians diagnosed <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> based on symptoms, followed by endoscopy in Japan and Korea, or in other countries, by the <z:chebi fb="0" ids="49200">proton-pump inhibitor</z:chebi> (<z:chebi fb="4" ids="53266">PPI</z:chebi>) test </plain></SENT>
<SENT sid="8" pm="."><plain>Heartburn was recognized as the chief complaint in <z:hpo ids='HP_0000001'>all</z:hpo> countries except Korea </plain></SENT>
<SENT sid="9" pm="."><plain>Most physicians in <z:hpo ids='HP_0000001'>all</z:hpo> countries used <z:chebi fb="4" ids="53266">PPI</z:chebi> as the first-line of treatment for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>Increasing the <z:chebi fb="4" ids="53266">PPI</z:chebi> dose was the treatment of choice for <z:chebi fb="4" ids="53266">PPI</z:chebi>-refractory erosive <z:hpo ids='HP_0100633'>esophagitis</z:hpo> in Korea, the Philippines, and Thailand </plain></SENT>
<SENT sid="11" pm="."><plain>In contrast, in other countries, physicians used a combination of <z:chebi fb="4" ids="53266">PPI</z:chebi> and other drugs to treat <z:chebi fb="4" ids="53266">PPI</z:chebi>-refractory erosive <z:hpo ids='HP_0100633'>esophagitis</z:hpo> </plain></SENT>
<SENT sid="12" pm="."><plain>Prescription of <z:chebi fb="0" ids="35469">antidepressant drugs</z:chebi> increased for <z:chebi fb="4" ids="53266">PPI</z:chebi>-refractory nonerosive reflux disease compared with <z:chebi fb="4" ids="53266">PPI</z:chebi>-refractory erosive <z:hpo ids='HP_0100633'>esophagitis</z:hpo> </plain></SENT>
<SENT sid="13" pm="."><plain>CONCLUSION: The findings in the present survey are useful to understand the current epidemiology, diagnosis, and treatment of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> in East Asian countries </plain></SENT>
</text></document>